"The highest quality in clinical trials. Our goal is to help science advance and help patients in need."

During the past decade, Invesclinic US LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Invesclinic US LLC" #1 sponsor was "Pulmotect, Inc." with 2 trials, followed by "Romark Laboratories L.C." with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "NewAmsterdam Pharma" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Invesclinic US LLC" #1 collaborator was "United States Department of Defense" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Invesclinic US LLC" are "COVID-19" (4 trials), "Arthritis, Rheumatoid" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Disease" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Invesclinic US LLC" in a lesser frequency.

Most popular intervention types in "Invesclinic US LLC" are "Drug" (9 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Nitazoxanide" (2 trials), "PUL-042 Inhalation Solution" (2 trials), "Vitamin Super B-Complex" (2 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Invesclinic US LLC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Invesclinic US LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Invesclinic US LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Invesclinic US LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".